Publication Details

Tracking of [18F]FDG-labeled natural killer cells to HER2/neu-positive tumors.

Meier R, Piert M, Piontek G, Rudelius M, Oostendorp RA, Senekowitsch-Schmidtke R, Henning TD, Wels WS, Uherek C, Rummeny EJ, Daldrup-Link HE. Nucl Med Biol. 2008; 35 (5): 579-88

The objective of this study was to label the human natural killer (NK) cell line NK-92 with [(18)F]fluoro-deoxy-glucose (FDG) for subsequent in vivo tracking to HER2/neu-positive tumors.

PubMedID: 18589302